These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

167 related articles for article (PubMed ID: 2863837)

  • 1. Aversive properties of naloxone in non-dependent (naive) rats may involve blockade of central beta-endorphin.
    Mucha RF; Millan MJ; Herz A
    Psychopharmacology (Berl); 1985; 86(3):281-5. PubMed ID: 2863837
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The role of the mediobasal arcuate hypothalamus in relation to opioid systems in the control of ingestive behaviour in the rat.
    Millan MJ; Millan MH; Reid LD; Herz A
    Brain Res; 1986 Aug; 381(1):29-42. PubMed ID: 2875765
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Involvement of beta-endorphin and mu-opioid receptors in mediating the aversive effect of lithium in the rat.
    Shippenberg TS; Millan MJ; Mucha RF; Herz A
    Eur J Pharmacol; 1988 Sep; 154(2):135-44. PubMed ID: 2852596
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Naloxone fails to produce conditioned place aversion in mu-opioid receptor knock-out mice.
    Skoubis PD; Matthes HW; Walwyn WM; Kieffer BL; Maidment NT
    Neuroscience; 2001; 106(4):757-63. PubMed ID: 11682161
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Depletion of central beta-endorphin blocks midbrain stimulation produced analgesia in the freely-moving rat.
    Millan MH; Millan MJ; Herz A
    Neuroscience; 1986 Jul; 18(3):641-9. PubMed ID: 2944030
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Different roles of mu-, delta- and kappa-opioid receptors in ethanol-associated place preference in rats exposed to conditioned fear stress.
    Matsuzawa S; Suzuki T; Misawa M; Nagase H
    Eur J Pharmacol; 1999 Feb; 368(1):9-16. PubMed ID: 10096764
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Endogenous enkephalins, not endorphins, modulate basal hedonic state in mice.
    Skoubis PD; Lam HA; Shoblock J; Narayanan S; Maidment NT
    Eur J Neurosci; 2005 Mar; 21(5):1379-84. PubMed ID: 15813947
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Motivational properties of kappa and mu opioid receptor agonists studied with place and taste preference conditioning.
    Mucha RF; Herz A
    Psychopharmacology (Berl); 1985; 86(3):274-80. PubMed ID: 2994144
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Stress-induced changes in plasma, pituitary and hypothalamic immunoreactive beta-endorphin: effects of diurnal variation, adrenalectomy, corticosteroids, and opiate agonists and antagonists.
    Lim AT; Funder JW
    Neuroendocrinology; 1983; 36(3):225-34. PubMed ID: 6300719
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Rewarding properties of beta-endorphin as measured by conditioned place preference.
    Amalric M; Cline EJ; Martinez JL; Bloom FE; Koob GF
    Psychopharmacology (Berl); 1987; 91(1):14-9. PubMed ID: 2950541
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of morphine and naloxone on the levels of ACTH and beta-endorphin in plasma, brain and pituitary of rats.
    Bruni G; Dal Pra P; Fiaschi AI; Segre G
    Pharmacol Res Commun; 1985 Jul; 17(7):659-69. PubMed ID: 2996032
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Differential effects of mu and kappa opioid systems on motivational processes.
    Shippenberg TS; Herz A
    NIDA Res Monogr; 1986; 75():563-66. PubMed ID: 2829003
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Antagonism of morphine-induced aversive conditioning by naloxone.
    LeBlanc AE; Cappell H
    Pharmacol Biochem Behav; 1975; 3(2):185-8. PubMed ID: 1144478
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The involvement of CRF1 receptor within the basolateral amygdala and dentate gyrus in the naloxone-induced conditioned place aversion in morphine-dependent mice.
    Valero E; Gómez-Milanés I; Almela P; Ribeiro Do Couto B; Laorden ML; Milanés MV; Núñez C
    Prog Neuropsychopharmacol Biol Psychiatry; 2018 Jun; 84(Pt A):102-114. PubMed ID: 29407532
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mu-, delta-, kappa- and epsilon-opioid receptor modulation of the hypothalamic-pituitary-adrenocortical (HPA) axis: subchronic tolerance studies of endogenous opioid peptides.
    Iyengar S; Kim HS; Wood PL
    Brain Res; 1987 Dec; 435(1-2):220-6. PubMed ID: 2892574
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of naloxone on conditioned suppression in rats.
    Vigorito M; Ayres JJ
    Behav Neurosci; 1987 Aug; 101(4):576-86. PubMed ID: 2820438
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Neurobiology of withdrawal motivation: evidence for two separate aversive effects produced in morphine-naive versus morphine-dependent rats by both naloxone and spontaneous withdrawal.
    Bechara A; Nader K; van der Kooy D
    Behav Neurosci; 1995 Feb; 109(1):91-105. PubMed ID: 7734084
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Naloxone eliminates passive avoidance retention deficits produced by pretest exposure to novelty in rats.
    Pinheiro AD; Wright DC
    Behav Neural Biol; 1991 May; 55(3):270-88. PubMed ID: 1647763
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Morphine sex-dependently induced place conditioning in adult Wistar rats.
    Karami M; Zarrindast MR
    Eur J Pharmacol; 2008 Mar; 582(1-3):78-87. PubMed ID: 18191832
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Central administration of nociceptin/orphanin FQ blocks the acquisition of conditioned place preference to morphine and cocaine, but not conditioned place aversion to naloxone in mice.
    Sakoori K; Murphy NP
    Psychopharmacology (Berl); 2004 Mar; 172(2):129-36. PubMed ID: 14624329
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.